PAMU
INSY

Pictet Asset Management (UK)’s Insys Therapeutics, Inc. INSY Stock Holding History

Pictet Asset Management (UK)’s Portfolio INSY Stock Details INSY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-157,126
Closed -$1.45M – 883
2016
Q4 		$1.45M Buy
157,126
+69,700
+80% +$787K 0.01% 782
2016
Q3 		$1.03M Hold
87,426
– – ﹤0.01% 781
2016
Q2 		$1.37M Buy
87,426
+36,026
+70% +$525K 0.01% 774
2016
Q1 		$898K Hold
51,400
– – ﹤0.01% 757
2015
Q4 		$1.47M Sell
51,400
-31,800
-38% -$881K 0.01% 756
2015
Q3 		$2.37M Buy
83,200
+6,700
+9% +$247K 0.01% 704
2015
Q2 		$3.44M Buy
+76,500
New +$2.38M 0.01% 668

Other funds holding INSY

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FHAM
Folger Hill Asset Management New York $16.5M AUM 19.96% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCP
Fine Capital Partners New York $563M AUM 7.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Pictet Asset Management (UK)'s INSY Position: Q1 2017 in Review

Pictet Asset Management (UK) sold out of Insys Therapeutics, Inc. (INSY) in Q1 2017, closing a stake of 157,126 shares — an estimated $1.45M sold.

Pictet Asset Management (UK) first reported a position in INSY in Q2 2015 and held it in 7 quarters. The position peaked at $3.44M in Q2 2015. 116 funds tracked by Wall St. Rank hold INSY as of Q1 2017.

  • Pictet Asset Management (UK) reported no remaining Insys Therapeutics, Inc. position as of Q1 2017 after selling out during the quarter.
  • Pictet Asset Management (UK) sold 157,126 Insys Therapeutics, Inc. shares in Q1 2017, an estimated $1.45M.
  • Pictet Asset Management (UK) first reported a position in Insys Therapeutics, Inc. in Q2 2015 and held it in 7 quarters.
  • Pictet Asset Management (UK)'s Insys Therapeutics, Inc. position peaked at $3.44M in Q2 2015.
  • 116 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q1 2017.

Based on Pictet Asset Management (UK)'s 13F filing for Q1 2017, filed 4 May 2017.